400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Cell Cycle / Kinesin / ARQ 621
CAS No.: 1095253-39-6
ARQ 621 is an allosteric, and selective Eg5 mitotic motor protein inhibitor.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00825487 | Metastatic Solid Tumors, Refra... more >>ctory/Relapsed Hematologic Malignancies Collapse << | Phase 1 | Completed | - | United States, Arizona ... more >> Translational Genomics Institute Phoenix, Arizona, United States, 85004 United States, California Premiere Oncology Santa Monica, California, United States, 90404 United States, Massachusetts Boston, Massachusetts, United States, 02111 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Collapse << |
实验方案
技术信息
CAS号 | 1095253-39-6 | 储存条件 |
|
|
分子式 | C28H24Cl2FN5O2 | 运输 | 蓝冰 | |
分子量 | 552.43 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00825487 | Metastatic Solid Tumors, Refra... more >>ctory/Relapsed Hematologic Malignancies Collapse << | Phase 1 | Completed | - | United States, Arizona ... more >> Translational Genomics Institute Phoenix, Arizona, United States, 85004 United States, California Premiere Oncology Santa Monica, California, United States, 90404 United States, Massachusetts Boston, Massachusetts, United States, 02111 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网